drugset / Trial / NCT00719823
Maraviroc Compassionate Use
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to provide Maraviroc on a compassionate use basis to antiretroviral treatment experienced patients infected with CCR5-tropic HIV-1 with urgent unmet medical needs and who, in the opinion of the physician, require Maraviroc to form a viable regimen.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | 150 mg | Oral |
| Subject | Maraviroc | Other / unclassified | 300 mg | Oral |
| Subject | Maraviroc | Other / unclassified | 600 mg | Oral |